Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

June 27, 2020

Shared genetic etiology underlying late-onset Alzheimer's disease and posttraumatic stress syndrome

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Michael W LutzOrnit Chiba-Falek
April 30, 2020
Open Access

Investigating APOE, APP-Aβ metabolism genes and Alzheimer's disease GWAS hits in brain small vessel ischemic disease

Scientific Reports
Sonja BlumenauCeleste Sassi
December 5, 2019
Open Access

Association of MS4A6A, CD33, and TREM2 gene polymorphisms with the late-onset Alzheimer's disease

BioImpacts : BI
Elham MehdizadehSasan Andalib
November 12, 2019
Open Access

Genome-Wide Association Studies for Cerebrospinal Fluid Soluble TREM2 in Alzheimer's Disease

Frontiers in Aging Neuroscience
Changan Liu, Jun Yu
August 16, 2019
Open Access

The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk

Science Translational Medicine
Y. DemingCarlos Cruchaga
July 6, 2019
Open Access

Integration of Alzheimer's disease genetics and myeloid genomics reveals novel disease risk mechanisms

BioRxiv : the Preprint Server for Biology
Gloriia NovikovaAlison Goate
March 25, 2019
Open Access

Genetics of Alzheimer's Disease

Dementia and Neurocognitive Disorders
Jong Hun Kim
March 13, 2019
Open Access

Shared genes between Alzheimer's disease and ischemic stroke

CNS Neuroscience & Therapeutics
Chang-Juan WeiXiao-Feng Ma
February 11, 2019
Open Access

Microglia in Alzheimer's Disease: Exploring How Genetics and Phenotype Influence Risk

Journal of Molecular Biology
Amanda McQuade, Mathew Blurton-Jones
November 19, 2018
Open Access

Translating Alzheimer's disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs

Neurobiology of Aging
Yuriko KatsumataDavid W Fardo
June 20, 2018
Open Access

The MS4A gene cluster is a key regulator of soluble TREM2 and Alzheimer disease risk

BioRxiv : the Preprint Server for Biology
Y. DemingCarlos Cruchaga
February 6, 2018

Recent studies on cellular and molecular mechanisms in Alzheimer's disease: focus on epigenetic factors and histone deacetylase

Reviews in the Neurosciences
Harikesh DubeyArunabha Ray
November 28, 2017
Open Access

A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease

Redox Biology
Sarah E LacherMatthew Slattery
June 27, 2017
Open Access

Functional annotation of Alzheimer's disease associated loci revealed by GWASs

PloS One
Zengpeng HanQingyang Huang
May 23, 2017
Open Access

A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer’s disease

BioRxiv : the Preprint Server for Biology
K.-l. HuangA L
May 10, 2017

Validating GWAS Variants from Microglial Genes Implicated in Alzheimer's Disease

Journal of Molecular Neuroscience : MN
Lígia Ramos Dos SantosFlavia de Paula
May 10, 2017
Open Access

African American exome sequencing identifies potential risk variants at Alzheimer disease loci

Neurology. Genetics
Aurelie N'SongoNilüfer Ertekin-Taner

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved